Shinichi Ban

Saitama Medical University

Papers

1

Total Citations

41

H-Index

1

About

Shinichi Ban is a leading figure in nephrology and renal immunopathology, whose research has significantly advanced our understanding of the renin-angiotensin system’s role in kidney inflammation. His most cited work, a 2006 study on immune-mediated glomerulonephritis, revealed a novel anti-inflammatory function of the angiotensin II type 2 receptor (AT2R) during type 1 receptor blockade. This finding challenged conventional views by demonstrating that AT2R activation can suppress renal inflammation, offering a potential therapeutic pathway for treating glomerular diseases. With over 41 citations, this seminal paper has influenced subsequent investigations into receptor-specific modulation in nephritis. Ban’s contributions extend to elucidating the complex interplay between immune cells and renal vasculature, providing mechanistic insights that bridge basic science and clinical nephrology. His work is particularly notable for its translational implications, guiding the development of more targeted, receptor-selective treatments that minimize side effects. For students and researchers, Ban’s research exemplifies how dissecting molecular pathways can uncover unexpected protective mechanisms, inspiring new strategies in autoimmune kidney disease management.

Research Focus

Key Achievements

1
H-Index
1
Papers
41
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
A Possible Anti-Inflammatory Role of Angiotensin II Type 2 Receptor in Immune-Mediated Glomerulonephritis during Type 1 Receptor Blockade
41 citations · 2006
📈 Most Prolific Year: 2006 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Saitama Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago